In the USA, figures from 2008 show that 33 million musculoskeletal injuries are reported per year, with 50% involving ligament and tendon injuries (James et al
However, l-dopa possesses many pharmacokinetic and pharmacodynamic drawbacks leading to pulsatility (short half-life), reduced availability (limited and variable reabsorption, and the requirement for declining aromatic l-amino acid decarboxylase), and off-target metabolism and sites (endothelium, glial cells, serotonin neurons and so on)
Fructose can also be used, but glucose is not a good choice of sugar substrate for methane SIBO
doi: 10.1038/ncomms7838 41 IvelandTSHagenLSharmaASousaMMLSarnoAWollenKLet al
Catherine Oseni, Pharm
But if you're trying to separate signal from noise, the honest answer is simple: BPC-157 is best known in research circles for tissue repair and recovery discussions (tendon/ligament, muscle, and gut integrity), not as a primary fat-loss compound